NIM
CGON icon

NEOS Investment Management’s CG Oncology CGON Stock Holding History

NEOS Investment Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,597
Closed -$1.52M – 595
2025
Q4 		$1.52M Buy
36,597
+6,372
+21% +$264K 0.01% 503
2025
Q3 		$1.22M Sell
30,225
-15,856
-34% -$461K 0.01% 491
2025
Q2 		$1.2M Buy
46,081
+17,469
+61% +$421K 0.01% 449
2025
Q1 		$701K Buy
28,612
+20,283
+244% +$571K 0.01% 482
2024
Q4 		$239K Buy
8,329
+817
+11% +$28K 0.01% 571
2024
Q3 		$283K Buy
7,512
+473
+7% +$16.6K 0.01% 546
2024
Q2 		$222K Buy
+7,039
New +$244K 0.01% 552

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NEOS Investment Management's CGON Position: Q1 2026 in Review

NEOS Investment Management sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 36,597 shares — an estimated $1.52M sold.

NEOS Investment Management first reported a position in CGON in Q2 2024 and held it in 7 quarters. The position peaked at $1.52M in Q4 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • NEOS Investment Management reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 36,597 CG Oncology shares in Q1 2026, an estimated $1.52M.
  • NEOS Investment Management first reported a position in CG Oncology in Q2 2024 and held it in 7 quarters.
  • NEOS Investment Management's CG Oncology position peaked at $1.52M in Q4 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.